AIToday
AI in HealthcarearXiv cs.CVPublished: Apr 30, 2026, 13:00 JST

Researchers develop a data-centric AI framework using fluorescence lifetime imaging to classify glioblastoma tumor margins with 96% accuracy

Send on LINE

3 Key Points

  1. Fluorescence lifetime imaging (FLIm) data were collected from 192 tissue margins across 31 newly diagnosed IDH-wildtype glioblastoma patients. An expert neuropathologist initially labeled these into seven tumor cellularity classes, which were then refined into three classes ('low', 'moderate', 'high') through confident learning (a method to identify and correct label errors).

  2. The resulting classifier achieved 96% accuracy in the three-class task. SHAP analysis (a technique for interpreting model predictions) revealed distinct optical signatures for tumor infiltration, and identified both biological factors (gray matter composition) and acquisition-related factors (blood contamination) that affected prediction confidence.

  3. Blinded re-evaluation of margins flagged by confident learning demonstrated intra-pathologist variability, showing that selective relabeling improved data reliability more than exhaustive review of all labels.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, every morning.

Send on LINE

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.

Questions and answers are published on this page.

Related Articles

Next articleMATH-PT benchmark dataset introduces 1,729 mathematical problems in European and Brazilian Portuguese to address linguistic bias in LLM reasoning evaluations